Literature DB >> 24878639

Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice.

Y H Connie Leung1, John M Nicholls2, Chuk Kwan Ho1, Sin Fun Sia1, Chris K P Mok3,1, Sophie A Valkenburg1, Peter Cheung1, Kenrie P Y Hui1, Renee W Y Chan1, Y Guan4,1, S Akira5, J S Malik Peiris4,3,1.   

Abstract

Toll-like receptors (TLRs) play an important role in innate immunity to virus infections. We investigated the role of TLR3 in the pathogenesis of H5N1 and pandemic H1N1 (pH1N1) influenza virus infections in mice. Wild-type mice and those defective in TLR3 were infected with influenza A/HK/486/97 (H5N1) or A/HK/415742/09 (pH1N1) virus. For comparison, mice defective in the gene for myeloid differential factor 88 (MyD88) were also infected with the viruses, because MyD88 signals through a TLR pathway different from TLR3. Survival and body weight loss were monitored for 14 days, and lung pathology, the lung immune-cell profile, viral load and cytokine responses were studied. H5N1-infected TLR3(-/-) mice had better survival than H5N1-infected WT mice, evident by significantly faster regain of body weight, lower viral titre in the lung and fewer pathological changes in the lung. However, this improved survival was not seen upon pH1N1 infection of TLR3(-/-) mice. In contrast, MyD88(-/-) mice had an increased viral titre and decreased leukocyte infiltration in the lungs after infection with H5N1 virus and poorer survival after pH1N1 infection. In conclusion, TLR3 worsens the pathogenesis of H5N1 infection but not of pH1N1 infection, highlighting the differences in the pathogenesis of these two viruses and the different roles of TLR3 in their pathogenesis.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24878639      PMCID: PMC4135086          DOI: 10.1099/vir.0.066258-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.

Authors:  Jungwoo Choe; Matthew S Kelker; Ian A Wilson
Journal:  Science       Date:  2005-06-16       Impact factor: 47.728

Review 2.  Update on avian influenza A (H5N1) virus infection in humans.

Authors:  Abdel-Nasser Abdel-Ghafar; Tawee Chotpitayasunondh; Zhancheng Gao; Frederick G Hayden; Duc Hien Nguyen; Menno D de Jong; Azim Naghdaliyev; J S Malik Peiris; Nahoko Shindo; Santoso Soeroso; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

3.  A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.

Authors:  Hideo Negishi; Tomoko Osawa; Kentaro Ogami; Xinshou Ouyang; Shinya Sakaguchi; Ryuji Koshiba; Hideyuki Yanai; Yoshinori Seko; Hiroshi Shitara; Keith Bishop; Hiromichi Yonekawa; Tomohiko Tamura; Tsuneyasu Kaisho; Choji Taya; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

4.  TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.

Authors:  Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Andrew B Sanders; William M Mitchell; Lena Alexopoulou; Richard A Flavell; Robert W Sidwell
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.

Authors:  T M Tumpey; X Lu; T Morken; S R Zaki; J M Katz
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection.

Authors:  Sang-Uk Seo; Hyung-Joon Kwon; Joo-Hye Song; Young-Ho Byun; Baik Lin Seong; Taro Kawai; Shizuo Akira; Mi-Na Kweon
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

7.  The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.

Authors:  Anne M Presanis; Daniela De Angelis; Angela Hagy; Carrie Reed; Steven Riley; Ben S Cooper; Lyn Finelli; Paul Biedrzycki; Marc Lipsitch
Journal:  PLoS Med       Date:  2009-12-08       Impact factor: 11.069

8.  Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease.

Authors:  Jay C Horvat; Kenneth W Beagley; Margaret A Wade; Julie A Preston; Nicole G Hansbro; Danica K Hickey; Gerard E Kaiko; Peter G Gibson; Paul S Foster; Philip M Hansbro
Journal:  Am J Respir Crit Care Med       Date:  2007-06-28       Impact factor: 21.405

9.  Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.

Authors:  Ronan Le Goffic; Viviane Balloy; Micheline Lagranderie; Lena Alexopoulou; Nicolas Escriou; Richard Flavell; Michel Chignard; Mustapha Si-Tahar
Journal:  PLoS Pathog       Date:  2006-06-09       Impact factor: 6.823

10.  Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation.

Authors:  Renee W Y Chan; Kit M Yuen; Wendy C L Yu; Carol C C Ho; John M Nicholls; J S Malik Peiris; Michael C W Chan
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more
  20 in total

Review 1.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

2.  Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.

Authors:  Lemme P Kebaabetswe; Anoria K Haick; Marina A Gritsenko; Thomas L Fillmore; Rosalie K Chu; Samuel O Purvine; Bobbie-Jo Webb-Robertson; Melissa M Matzke; Richard D Smith; Katrina M Waters; Thomas O Metz; Tanya A Miura
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

3.  Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.

Authors:  Michael C W Chan; Denise I T Kuok; Connie Y H Leung; Kenrie P Y Hui; Sophie A Valkenburg; Eric H Y Lau; John M Nicholls; Xiaohui Fang; Yi Guan; Jae W Lee; Renee W Y Chan; Robert G Webster; Michael A Matthay; J S Malik Peiris
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

4.  Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.

Authors:  Allison L Totura; Alan Whitmore; Sudhakar Agnihothram; Alexandra Schäfer; Michael G Katze; Mark T Heise; Ralph S Baric
Journal:  mBio       Date:  2015-05-26       Impact factor: 7.867

5.  --LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation.

Authors:  Julia Zinngrebe; Eva Rieser; Lucia Taraborrelli; Nieves Peltzer; Torsten Hartwig; Hongwei Ren; Ildikó Kovács; Cornelia Endres; Peter Draber; Maurice Darding; Silvia von Karstedt; Johannes Lemke; Balazs Dome; Michael Bergmann; Brian J Ferguson; Henning Walczak
Journal:  J Exp Med       Date:  2016-10-24       Impact factor: 14.307

6.  CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.

Authors:  Ooiean Teng; Szu-Ting Chen; Tsui-Ling Hsu; Sin Fun Sia; Suzanne Cole; Sophie A Valkenburg; Tzu-Yun Hsu; Jian Teddy Zheng; Wenwei Tu; Roberto Bruzzone; Joseph Sriyal Malik Peiris; Shie-Liang Hsieh; Hui-Ling Yen
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 7.  A Role for Neutrophils in Viral Respiratory Disease.

Authors:  Jeremy V Camp; Colleen B Jonsson
Journal:  Front Immunol       Date:  2017-05-12       Impact factor: 7.561

8.  A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection.

Authors:  Jonathan Maelfait; Kenny Roose; Lars Vereecke; Conor Mc Guire; Mozes Sze; Martijn J Schuijs; Monique Willart; Lorena Itati Ibañez; Hamida Hammad; Bart N Lambrecht; Rudi Beyaert; Xavier Saelens; Geert van Loo
Journal:  PLoS Pathog       Date:  2016-01-27       Impact factor: 6.823

9.  Novel strategies for targeting innate immune responses to influenza.

Authors:  K A Shirey; W Lai; M C Patel; L M Pletneva; C Pang; E Kurt-Jones; M Lipsky; T Roger; T Calandra; K J Tracey; Y Al-Abed; A G Bowie; A Fasano; C A Dinarello; F Gusovsky; J C G Blanco; S N Vogel
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

10.  HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections.

Authors:  Lei Sun; Zhengfan Jiang; Victoria A Acosta-Rodriguez; Michael Berger; Xin Du; Jin Huk Choi; Jianhui Wang; Kuan-Wen Wang; Gokhul K Kilaru; Jennifer A Mohawk; Jiexia Quan; Lindsay Scott; Sara Hildebrand; Xiaohong Li; Miao Tang; Xiaoming Zhan; Anne R Murray; Diantha La Vine; Eva Marie Y Moresco; Joseph S Takahashi; Bruce Beutler
Journal:  J Exp Med       Date:  2017-10-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.